| 000 | 01638cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 110407s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.33.M.Sc.2010.Ga.D | ||
| 100 | 0 | _aGasem Mohammad Shawish Almasri | |
| 245 | 1 | 0 |
_aDiabetic chronic HCV patients and their response to interferon therapy / _cGasem Mohammad Shawish Almasri ; Supervised Maissa Alraziky , Wafaa Ahmed Alakel , Ahmed Fouad Soliman |
| 246 | 1 | 5 | _aمرضى البول السكرى فى مرضى الالتهاب الفيروسى المزمن (س) ومدى تأثيرة على الاستجابة للعلاج الفيرسى |
| 260 |
_aCairo : _bGasem Mohammad Shawish Almasri , _c2010 |
||
| 300 |
_a168P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine | ||
| 520 | _aHepatitis C virus is a major puplic health problem and is considered the most common etiology of chronic liver disease in Egypt . Serum blood glucose and HbA1C are most commonly measured in diabetic patients with hepatic disease . Diabetes may decrease response to interferon therapy and decrease early virological response | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChronic HCV | |
| 653 | 4 | _aDiabetes mellitus | |
| 653 | 4 | _aPredictors of response | |
| 700 | 0 |
_aAhmed Fouad Soliman , _eSupervisor |
|
| 700 | 0 |
_aMaissa Alraziky , _eSupervisor |
|
| 700 | 0 |
_aWafaa Ahmed Alakel , _eSupervisor |
|
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c33594 _d33594 |
||